Fibromyalgia syndrome (FMS) is one of the most common chronic pain conditions out there, yet we still know shockingly little about it.

For decades, the debilitating condition — marked by widespread pain and fatigue — has been vastly understudied, and while it’s commonly thought to originate in the brain, no one really knows how fibromyalgia starts or what can be done to treat it. Some physicians maintain it doesn’t even exist, and many patients report feeling gaslit by the medical community.

New research on mice has now found further evidence that fibromyalgia is not only real, but may involve an autoimmune response as a driver for the illness.

Of the 88 neurosurgical patients, 30 showed a decrease in self-reported spiritual belief before and after neurosurgical brain tumor resection, 29 showed an increase, and 29 showed no change. Using lesion network mapping, the team found that self-reported spirituality mapped to a specific brain circuit centered on the PAG. The circuit included positive nodes and negative nodes — lesions that disrupted these respective nodes either decreased or increased self-reported spiritual beliefs.

Summary: A new study has identified a specific brain circuit centered in the periaqueductal gray that is linked to spiritual acceptance and religiosity.

Source: Brigham and Women’s Hospital

More than 80 percent of people around the world consider themselves to be religious or spiritual. But research on the neuroscience of spirituality and religiosity has been sparse. Previous studies have used functional neuroimaging, in which an individual undergoes a brain scan while performing a task to see what areas of the brain light up. But these correlative studies have given a spotty and often inconsistent picture of spirituality.

The human body contains hundreds of different types of cells, with stem cells working like blank canvases that can be adapted and reproduced to help our tissues grow and repair themselves. However, once hijacked, the same kind of cell proliferation can be damaging, as happens in cancer tumors.

Scientists have now discovered a new resting phase for neuroepithelial cells — the stem cells of the central nervous system — which appears to put them in a kind of dormancy. If we can work out how to apply this to cancer cells too, we could get to the stage of being able to put brain tumors to ‘sleep’.

“The primary feature of any cancer is that the cells are proliferating,” says biomedical engineer Christopher Plaisier, from Arizona State University. “If we could get in there and figure out what the mechanisms are, that might be a place to slow them down.”

Summary: Study finds amyloid-beta plaques may not be the cause of memory loss associated with Alzheimer’s disease, but instead a consequence of the disease. Regardless of the levels of amyloid plaques, researchers found individuals with high levels of amyloid peptide were cognitively normal. Higher levels of soluble amyloid beta peptide were also linked to people having a larger hippocampus.

Source: University of Cincinnati.

Experts estimate more than 6 million Americans are living with Alzheimer’s dementia. But a recent study, led by the University of Cincinnati, sheds new light on the disease and a highly debated new drug therapy.